Financial Operations Insights, Guides, and Tools
Cash vs. Accrual Accounting for Longevity Clinics and Wellness Practices
When launching a new longevity clinic or wellness practice, it’s vital to establish sound accounting strategies at the outset. One of the choices you’ll make is whether to apply a cash or accrual accounting method. While it may seem like “potatoes-patatoes” to you, there are implications to each method that will inform compliance activities, future growth, and how you understand the practice’s financial health.
Sales and Use Tax in Healthcare and Medical Products: Common Exposure Areas
The medical products sector covers a vast array of products and services, making compliance a complicated undertaking at the best of times. For life sciences startups (and companies at any growth stage, for that matter), this introduces many challenges, not the least of which is financial, tax, and compliance exposure.
Proper Tax and Accounting Treatment for Gift Cards and Package Credits
Wellness and longevity clinics operate on a different business model than most healthcare organizations. With retail, lifestyle, diagnostics, and health services under a single umbrella, deferred revenue is the norm. And while recurring payments from memberships and subscriptions can provide sustainable income, they come with some complexities.
Internal Controls for Life Sciences Startups: The “Pre-Audit” Checklist
Life sciences startups are typically not laser-focused on anything beyond innovation and their current projects, and finding the funding they need to keep it all going. However, without proper internal controls and SOPs, compliance and regulatory approvals may be challenging.
Clinical Trial Accruals: How Finance Teams Avoid Quarter-End Surprises
Clinical trials are complex endeavors, often spanning years and rarely aligning with a company’s accounting periods. And therein lies the challenge: how do finance teams accurately track trial accrual and avoid nasty surprises when closing out the quarter? When the numbers don’t line up, there is a distinct ripple effect in financial statements, and investors and decision-makers will undoubtedly feel the consequences.